Searchable abstracts of presentations at key conferences in endocrinology

ea0029p354 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Control of acromegaly in an era where it is technically feasible in almost every patient, is by no means invariable even in a specialist unit

Szamocki S. , Karavitaki N. , Wass J.

We have audited control of acromegaly in a specialist endocrine unit in Oxford now that this should usually obtainable. We have 240 patients under active surveillance, seen annually since diagnosis. Data from 115 of these seen in the last year have been used for this analysis.Methods: We grouped patients according to whether they were controlled in either or both IGF1 and GH or uncontrolled. Controlled IGF1 was defined according to age and sex and GH was...